表 2.

两组患者并存疾病及感染的潜在危险因素

Comorbidities and potential risk factors for infection in two groups

Items	Group A (n=21)	Group B (n=12)	P value
Glucocorticoid and immunosuppressant use, n(%)	9 (42.9)	5 (41.7)	1.000
Rheumatic and immune diseases, n(%)	7 (33.3)	4 (33.3)	0.723
Diabetes mellitus, n(%)	3 (14.3)	4 (33.3)	0.377
Solid cancer, n(%)	2 (9.5)	1 (8.3)	1.000
Intra-articular injection, n(%)	5 (23.8)	2 (16.7)	1.000
Skin disease, n(%)	3 (14.3)	2 (16.7)	1.000
Cacotrophy, n(%)	7 (33.3)	3 (25.0)	0.710
Other chronic disease, n(%)	10 (47.6)	6 (50.0)	1.000